P

Inventor

MARY CAROLINE

FR23 patents
⚠️ This page may combine multiple inventors who share the name “MARY CAROLINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OSE IMMUNOTHERAPEUTICS

17 patents
US11440964B2Sep 13, 2022

Method for treating a pathological condition involving the activation or proliferation of CD127 positive cells with an anti-CD127 antibody

OSE IMMUNOTHERAPEUTICS2 citations72
US11230602B2Jan 25, 2022

Non-antagonistic antibodies directed against the alpha chain of the IL7 receptor extracellular domain and use thereof in cancer treatment

OSE IMMUNOTHERAPEUTICS2 citations72
US10428152B2Oct 1, 2019

Antibodies directed against CD127

OSE IMMUNOTHERAPEUTICS3 citations72
US10364287B2Jul 30, 2019

Anti-CD28 humanized antibodies

OSE IMMUNOTHERAPEUTICS3 citations72
US11279766B2Mar 22, 2022

Anti-SIRPa antibodies and their therapeutic applications

OSE IMMUNOTHERAPEUTICS3 citations70
US11352430B2Jun 7, 2022

Humanized anti-human-PD-1 antibody and its use in cancer treatment

OSE IMMUNOTHERAPEUTICS2 citations68
US12371502B2Jul 29, 2025

Antibodies directed against CD127

OSE IMMUNOTHERAPEUTICS0 citations62
US11926671B2Mar 12, 2024

Antibodies and polypeptides directed against CD127

OSE IMMUNOTHERAPEUTICS0 citations61
US11098128B2Aug 24, 2021

Antibodies and polypeptides directed against CD127

OSE IMMUNOTHERAPEUTICS1 citations61
US12331115B2Jun 17, 2025

Uses of anti-SIRPg antibodies

OSE IMMUNOTHERAPEUTICS0 citations59
US12252546B2Mar 18, 2025

Anti-SIRPa antibodies and their therapeutic applications

OSE IMMUNOTHERAPEUTICS0 citations59
US12331118B2Jun 17, 2025

Humanized anti-human-PD-1 antibody and methods of using them for cancer treatment

OSE IMMUNOTHERAPEUTICS0 citations57
US12534533B2Jan 27, 2026

Anti-chemokine like receptor 1 humanized antibodies and their therapeutic applications

OSE IMMUNOTHERAPEUTICS0 citations56
US11713356B2Aug 1, 2023

Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer

OSE IMMUNOTHERAPEUTICS0 citations51
US11884723B2Jan 30, 2024

Use of anti-human SIRPa v1 antibodies and method for producing anti-SIRPa v1 antibodies

OSE IMMUNOTHERAPEUTICS0 citations49
US10689444B2Jun 23, 2020

Recombinant monovalent antibodies

OSE IMMUNOTHERAPEUTICS0 citations47
US12448454B2Oct 21, 2025

Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof

OSE IMMUNOTHERAPEUTICS0 citations45

EFFIMUNE

2 patents

VANHOVE BERNARD

2 patents

MARY CAROLINE

1 patent

SNECMA

1 patent